![](/img/cover-not-exists.png)
First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer
Shapiro, G. I., Bell-McGuinn, K. M., Molina, J. R., Bendell, J., Spicer, J., Kwak, E. L., Pandya, S. S., Millham, R., Borzillo, G., Pierce, K. J., Han, L., Houk, B. E., Gallo, J. D., Alsina, M., BranaVolume:
21
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-14-1306
Date:
April, 2015
File:
PDF, 400 KB
english, 2015